Source: Abstracts. Conference titles: Annual Meeting and Exposition of the American Society of Hematology. Unidades: FMRP, FCFRP
Subjects: CLÍNICA GERAL, LEUCEMIA MIELOIDE, INSULINA
ABNT
MACHADO NETO, João Agostinho et al. Multitarget antileukemic effects of metformin in myeloproliferative neoplasm cells: inhibition of JAK2/STAT signaling and mitochondrial activity. 2016, Anais.. San Diego: ASH, 2016. Disponível em: http://www.bloodjournal.org/content/128/22/1960. Acesso em: 15 out. 2024.APA
Machado Neto, J. A., Fenerich, B. A., Scopim-Ribeiro, R., Dechandt, C. R. P., Alves, A. P. N. R., Fernandes, J. C., et al. (2016). Multitarget antileukemic effects of metformin in myeloproliferative neoplasm cells: inhibition of JAK2/STAT signaling and mitochondrial activity. In Abstracts. San Diego: ASH. Recuperado de http://www.bloodjournal.org/content/128/22/1960NLM
Machado Neto JA, Fenerich BA, Scopim-Ribeiro R, Dechandt CRP, Alves APNR, Fernandes JC, Scheucher PS, Simões BP, Alberici LC, Pontes LL de F, Rego EM, Traina F. Multitarget antileukemic effects of metformin in myeloproliferative neoplasm cells: inhibition of JAK2/STAT signaling and mitochondrial activity [Internet]. Abstracts. 2016 ;[citado 2024 out. 15 ] Available from: http://www.bloodjournal.org/content/128/22/1960Vancouver
Machado Neto JA, Fenerich BA, Scopim-Ribeiro R, Dechandt CRP, Alves APNR, Fernandes JC, Scheucher PS, Simões BP, Alberici LC, Pontes LL de F, Rego EM, Traina F. Multitarget antileukemic effects of metformin in myeloproliferative neoplasm cells: inhibition of JAK2/STAT signaling and mitochondrial activity [Internet]. Abstracts. 2016 ;[citado 2024 out. 15 ] Available from: http://www.bloodjournal.org/content/128/22/1960